Abstract
Abstract Determinants of the response to coumarin anticoagulant, warfarin, have been analysed in a series of 19 patients with acute myocardial infarction. Cardiac failure developing in the acute phase of the disease seemed to be without any great influence on the plasma half‐life of warfarin, with the exception of patients in whom serious circulatory catastrophes occurred. In patients who had received other drugs regularly before the hospital admission the plasma half‐life of warfarin showed a significant prolongation within 3 weeks—a phenomenon apparently caused by a decreasing induction of microsomal drug‐metabolizing enzymes in the liver. The plasma half‐life of warfarin was found to explain 44% of the variance in the daily requirement of warfarin during maintenance treatment. The steady state “therapeutic” plasma warfarin level showed a wide range of individual variation—from 0.8 to 4.1 mg/l, with a median value of 1.5 mg/l. The results indicate that in addition to the rate of coumarin anticoagulant metabolism other factors have a marked influence on the response to coumarin drugs in patients with myocardial infarction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
